Iovance Biotherapeutics, Inc.
Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

Last updated:

Abstract:

The present invention provides improved and/or shortened methods for expanding TILs and producing therapeutic populations of TILs, including novel methods for expanding TIL populations in a closed system that lead to improved efficacy, improved phenotype, and increased metabolic health of the TILs in a shorter time period, while allowing for reduced microbial contamination as well as decreased costs. Such TILs find use in therapeutic treatment regimens.

Status:
Grant
Type:

Utility

Filling date:

22 Jul 2021

Issue date:

15 Mar 2022